Worldwide, an estimated ten percent of women of reproductive age are affected by endometriosis, a chronic disease characterised by the growth of endometrium-like tissue outside of the uterus. This leads to symptoms such as severe pain, especially during menstruation, or infertility. Despite its prevalence, endometriosis is often incorrectly diagnosed, and the cause of the disease is still largely unknown. On Thursday 7 March, experts will examine the causes, symptoms, and treatment of endometriosis in an international virtual panel discussion.
The Leopoldina International Virtual Panel provides a platform for exchanging knowledge, ideas, and perspectives on ongoing research efforts. In addition to the latest research findings on the causes and symptoms of endometriosis, the panel will also discuss strategies for diagnosing, treating, and supporting patients from an evidence-based perspective. The Leopoldina will welcome the following experts to the panel discussion.
This event is open to all interested parties and will be held in English. Admission is free of charge. Please register before the event.
This event is part of the Leopoldina’s “International Panel Series”, organised in cooperation with its international partners. The virtual panels provide a space for dialogue between leading scientists and the general public. Previous panels addressed the coronavirus pandemic from different angles, including vaccination, multimorbidity, mental health, contact tracing, and long COVID.
“Chasing the Chameleon: Advances in the Diagnosis and Treatment of Endometriosis” (2024)
“Understanding Long Covid” (2023)
“Science Communication in Times of COVID-19 under the Spotlight” (2021)
“The Role of Data in the COVID-19 Pandemic” (2021)
“COVID-19 and Human Health Behavior: Impacts and Trends” (2021)
“Challenges in COVID-19 Vaccination“ (2021)
“COVID-19 and Multimorbidity: How to Deal with Multiple Infectious Diseases in Parallel?“(2020)
“The Hidden Crisis: Mental Health in Times of COVID-19“ (2020)
“Contact Tracing Apps: Promising Tool in the Fight Against COVID-19?“ (2020)